In collaboration with the School of Public Health at the University of California, Berkeley, we aim to build the evidence base needed to inform policy decisions on appropriate levels of access to depo medroxy progesterone acetate (DMPA) for distribution.  In Ethiopia, where the unmet need for family planning is staggeringly high, DMPA is the preferred method.  Together with the Ethiopian Ministry of Health we have initiated operations research to determine if community-based distribution and administration of DMPA is a safe and feasible way to better meet the family planning needs of that country's women.